Atlas Trials

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder

Clinical trial NCT06270433 · UNKNOWN

Trial details

NCT number
NCT06270433
Sponsor
Jiangsu Province Nanjing Brain Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Anhedonia
Start date
2024-02-19
Primary completion
2024-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.